Study guide

8.5 Serous Effusions & Synovial Fluid Analysis

ASCP Hematology Technologist Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Hematopoiesis & Cellular Physiology

1.1 Hematopoiesis, Bone Marrow Microenvironment & Growth Factors 1.2 Erythrocyte Physiology, Metabolism & Destruction Pathways 1.3 Leukocyte Kinetics, Morphology & Phagocytic Function 1.4 Platelet Physiology, Ultrastructure & Thrombopoiesis

2 Chapter 2: Erythrocyte Disorders & Non-Hemolytic Anemias

2.1 Iron Metabolism & Iron Deficiency Anemia 2.2 Anemia of Chronic Inflammation, Sideroblastic Anemias & Lead Toxicity 2.3 Hemoglobinopathies & Qualitative Globin Chain Defects 2.4 Alpha and Beta Thalassemias 2.5 Megaloblastic, Macrocytic & Hypoproliferative Anemias

3 Chapter 3: Hemolytic Anemias & Erythrocytosis

3.1 Intrinsic Hemolytic Anemias: Membrane & Metabolic Defects 3.2 Immune-Mediated Hemolytic Anemias & Paroxysmal Nocturnal Hemoglobinuria 3.3 Non-Immune Extrinsic Hemolytic Anemias & Microangiopathies 3.4 Polycythemia & Erythrocytosis Classification

4 Chapter 4: Benign Leukocyte Alterations, Acute Leukemias & Bone Marrow Evaluation

4.1 Quantitative Leukocyte Alterations, Toxic Change & Leukemoid Reaction 4.2 Inherited Leukocyte Anomalies, Reactive Lymphocytosis & Storage Disorders 4.3 Acute Myeloid Leukemia (AML) & Related Neoplasms 4.4 Acute Lymphoblastic Leukemia (ALL) & Precursor Lymphoid Neoplasms 4.5 Bone Marrow Examination, Differential & M:E Ratio Assessment

5 Chapter 5: Chronic Myeloid Neoplasms, MDS & Mature Lymphoid Neoplasms

5.1 Myelodysplastic Syndromes (MDS) & Overlap Syndromes 5.2 Chronic Myeloproliferative Neoplasms (CML, PV, ET, PMF) 5.3 Chronic Lymphocytic Leukemia & Indolent B-Cell Lymphomas 5.4 Aggressive Lymphomas, Hodgkin Lymphoma & Mature T-Cell Disorders 5.5 Plasma Cell Neoplasms & Monoclonal Gammopathies

6 Chapter 6: Hemostasis: Primary, Secondary & Fibrinolytic Systems

6.1 Primary Hemostasis, Platelet Receptors & Qualitative Platelet Disorders 6.2 Quantitative Platelet Disorders & Immune Thrombocytopenias 6.3 The Coagulation Cascade & Cell-Based Hemostatic Model 6.4 Fibrinolytic System, Natural Anticoagulants & Thrombophilia

7 Chapter 7: Factor Deficiencies, Coagulation Testing & Anticoagulation

7.1 Hereditary Coagulation Factor Deficiencies & von Willebrand Disease 7.2 Acquired Coagulation Factor Deficiencies, Circulating Inhibitors & DIC 7.3 Routine and Specialized Coagulation Testing & Mixing Study Interpretation 7.4 Anticoagulant Therapies, Laboratory Monitoring & Reversal Strategies 7.5 Viscoelastic Testing, Heparin Neutralization & Chromogenic Assays

8 Chapter 8: Hematology Laboratory Testing & Advanced Diagnostics

8.1 Automated Hematology Analyzers, Interference Flags & Manual Methods 8.2 Cytochemical Staining, Flow Cytometry & Molecular Diagnostics 8.3 Erythrocyte Sedimentation Rate, Hemolytic Indicators & Special Erythrocyte Studies 8.4 Cerebrospinal Fluid Analysis, Cell Counts & Cytology 8.5 Serous Effusions & Synovial Fluid Analysis

9 Chapter 9: Laboratory Operations, Quality Assessment & Safety

9.1 The Total Testing Process: Preanalytical, Analytical & Postanalytical Quality 9.2 Quality Control Statistics, Levey-Jennings Charts & Westgard Multirules 9.3 Laboratory Mathematics: Dilutions, Concentration, Molarity & Standard Curves 9.4 Method Evaluation, Diagnostic Statistics & Point-of-Care Testing 9.5 Regulatory Framework, Proficiency Testing & Competency Assessment 9.6 Laboratory Safety: Bloodborne Pathogens, Personal Protective Equipment & Chemical Hygiene 9.7 Emergency Response, Spill Management & Specimen Packaging and Transport 9.8 Hematology Instrumentation: Microscopy, Counters, Analyzers & Centrifuges

8.5 Serous Effusions & Synovial Fluid Analysis

Key Takeaways Explain This Topic AI

Light's criteria classify an effusion as an exudate if ANY ONE is met: fluid/serum protein ratio above 0.5, fluid/serum LDH ratio above 0.6, or fluid LDH above two thirds of the upper limit of normal serum LDH.

A serum-ascites albumin gradient of 1.1 g/dL or more indicates portal hypertension, whereas a gradient below 1.1 g/dL indicates peritoneal carcinomatosis, tuberculosis, or pancreatitis.

Monosodium urate crystals are needle-shaped with strong NEGATIVE birefringence and appear yellow when parallel to the slow axis (gout); calcium pyrophosphate dihydrate crystals are rhomboid with weak POSITIVE birefringence and appear blue when parallel (pseudogout).

Synovial fluid for crystal analysis must be collected in sodium heparin or LIQUID EDTA, because powdered anticoagulants form birefringent artifacts that mimic pathologic crystals.

Reactive mesothelial cells show clear intercellular 'windows' and uniform nuclei, whereas malignant adenocarcinoma cells form three-dimensional clusters with pleomorphism, high nuclear-to-cytoplasmic ratio, and mucin vacuoles.

Last updated: August 2026

Serous Effusions & Synovial Fluid Analysis

Serous fluids and synovial fluid arrive in the hematology laboratory for cell counts, cytospin differentials, and crystal examination. The ASCP BOC composite reference range table gives synovial fluid WBC as 0 to 200 per microlitre with fewer than 25% polymorphonuclear cells, and examination items typically pair a fluid chemistry pattern with a microscopic finding.

  • Serous Effusions & Synovial Fluid Analysis
  • 1. Serous Effusions (Pleural, Peritoneal, Pericardial)

Serous cavities are lined by a parietal membrane and visceral membrane lubricated by a thin film of plasma ultrafiltrate. Pathologic fluid accumulation is classified using Light's Criteria :

Light's Criteria for Exudates (Meets ≥ 1 \ge 1 ≥ 1 of the following):

Pleural Fluid Protein / Serum Protein Ratio > 0.5 \text{Pleural Fluid Protein} / \text{Serum Protein Ratio} > 0.5 Pleural Fluid Protein / Serum Protein Ratio > 0.5

Pleural Fluid LDH / Serum LDH Ratio > 0.6 \text{Pleural Fluid LDH} / \text{Serum LDH Ratio} > 0.6 Pleural Fluid LDH / Serum LDH Ratio > 0.6

Pleural Fluid LDH > 2 3 of the Upper Limit of Normal Serum LDH \text{Pleural Fluid LDH} > \frac{2}{3} \text{ of the Upper Limit of Normal Serum LDH} Pleural Fluid LDH > 3 2 ​ of the Upper Limit of Normal Serum LDH

Parameter Transudate (Systemic Etiology) Exudate (Local Pathology)

Primary Pathophysiology Imbalance in systemic hydrostatic pressure (CHF) or decreased oncotic pressure (cirrhosis, nephrotic syndrome) Local inflammation, infection, vascular permeability, or malignant tumor infiltration

Fluid Appearance Pale yellow, clear, serous Cloudy, turbid, purulent, chylous, or hemorrhagic

Total Protein ≤ 3.0 g/dL \le 3.0\text{ g/dL} ≤ 3.0 g/dL (Fluid/Serum Protein ≤ 0.5 \le 0.5 ≤ 0.5 ) > 3.0 g/dL >3.0\text{ g/dL} > 3.0 g/dL (Fluid/Serum Protein > 0.5 >0.5 > 0.5 )

Lactate Dehydrogenase (LDH) ≤ 200 U/L \le 200\text{ U/L} ≤ 200 U/L (Fluid/Serum LDH ≤ 0.6 \le 0.6 ≤ 0.6 ) > 200 U/L >200\text{ U/L} > 200 U/L (Fluid/Serum LDH > 0.6 >0.6 > 0.6 )

Total Leukocyte Count Low ( < 1 , 000 / μ L <1,000/\mu\text{L} < 1 , 000/ μ L ); predominantly mononuclear High ( > 1 , 000 to > 10 , 000 / μ L >1,000\text{ to }>10,000/\mu\text{L} > 1 , 000 to > 10 , 000/ μ L ); neutrophils or malignant cells

Serum-Ascites Albumin Gradient (SAAG) ≥ 1.1 g/dL \ge 1.1\text{ g/dL} ≥ 1.1 g/dL (indicates portal hypertension: cirrhosis, cardiac ascites) < 1.1 g/dL <1.1\text{ g/dL} < 1.1 g/dL (indicates peritoneal carcinomatosis, peritoneal TB, pancreatitis)

Cytopreparation & Cytological Differential

To preserve cell morphology and prevent cell rupture during slide preparation, body fluids are processed using a cytocentrifuge (Cytospin) at 500 to 800 rpm 500\text{ to }800\text{ rpm} 500 to 800 rpm for 5 minutes with the addition of 22 % 22\% 22% bovine serum albumin (BSA) :

Reactive Mesothelial Cells: Shed from cavity linings; large cells ( 15 – 30 μ m 15\text{--}30\ \mu\text{m} 15 – 30 μ m ) displaying round central/eccentric nuclei, prominent nucleoli, deep basophilic cytoplasm, and characteristic clear intercellular "windows" (microvillar clearance between adjacent cells). Binucleated and multinucleated forms are common.

Malignant Adenocarcinoma Clusters: Form three-dimensional ball-like clusters, displaying extreme nuclear pleomorphism, nuclear cannibalism, high N:C ratio, irregular chromatin clumping, and prominent vacuolization (mucin-producing signet ring cells).

2. Synovial Fluid & Compensated Polarized Light Microscopy

Synovial fluid is aspirated from joints (arthrocentesis) and collected in sodium heparin or liquid EDTA for crystal and cell analysis (powdered anticoagulants must be avoided as they create birefringent crystal artifacts). COMPENSATED POLARIZED LIGHT CRYSTAL IDENTIFICATION

  • (First-Order Red Compensator Plate)
  • │
  • ┌─────────────────────────────┴─────────────────────────────┐
  • ▼ ▼
  • [ MONOSODIUM URATE (MSU) ] [ CALCIUM PYROPHOSPHATE (CPPD) ]
  • Shape: Needle-shaped, pointed ends - Shape: Small rhomboid, rectangular rods
  • Birefringence: Strongly NEGATIVE - Birefringence: Weakly POSITIVE

- Alignment PARALLEL to Slow Axis: - Alignment PARALLEL to Slow Axis:

===> Bright YELLOW ===> Pale BLUE

- Alignment PERPENDICULAR to Slow Axis: - Alignment PERPENDICULAR to Slow Axis:

  • ===> Bright BLUE ===> Pale YELLOW
  • Mnemonic: [ Y U P ] - Pathology: Pseudogout /
  • (Yellow Urate Parallel) Chondrocalcinosis
  • Pathology: Acute Gout

Crystal Type Chemical Composition Morphology Optical Birefringence Color when Parallel to Slow Axis Color when Perpendicular Associated Clinical Disease

Monosodium Urate (MSU) Uric acid / monosodium salt Fine, needle-like crystals with sharp, pointed ends ( 2 – 20 μ m 2\text{--}20\ \mu\text{m} 2 – 20 μ m ) Strongly Negative Birefringence Bright Yellow Bright Blue Acute Gouty Arthritis

Calcium Pyrophosphate Dihydrate (CPPD) Calcium pyrophosphate Small, rectangular, rod-shaped, or rhomboid crystals ( 1 – 10 μ m 1\text{--}10\ \mu\text{m} 1 – 10 μ m ) Weakly Positive Birefringence Pale Blue Pale Yellow Pseudogout (Chondrocalcinosis)

Cholesterol Crystals Free cholesterol Large, flat rectangular plates with notched corners Strongly positive / variable Multicolor / variable Multicolor / variable Chronic rheumatoid arthritis effusions

Synovial Fluid Classification Groups

Synovial fluid results are reported against four diagnostic categories, and the total leukocyte count with its neutrophil percentage does most of the classifying work.

  • Group Total WBC (per uL) Neutrophils Appearance and Viscosity Representative Causes
  • Normal 0-200 (ASCP BOC composite range) Less than 25% Clear, pale yellow, HIGH viscosity Healthy joint

Group I - Non-inflammatory 200-2,000 Less than 30% Clear to slightly turbid, viscosity retained Osteoarthritis, traumatic effusion

Group II - Inflammatory 2,000-75,000 (occasionally higher in crystal disease) Often above 50% Turbid, yellow, viscosity DECREASED Rheumatoid arthritis, gout, pseudogout, systemic lupus erythematosus

Group III - Septic Usually above 50,000, frequently above 100,000 Above 75-90% Purulent, opaque, viscosity lost Bacterial septic arthritis; Gram stain and culture are mandatory

Group IV - Hemorrhagic Variable, with abundant red cells Variable Grossly bloody, uniform across aliquots Trauma, hemophilia, anticoagulant excess, pigmented villonodular synovitis

Crystal-induced arthritis can drive counts into the septic range, so crystals never exclude infection: both examinations are performed on the same specimen.

Viscosity and the Mucin Clot

Synovial viscosity comes from polymerized hyaluronate secreted by synoviocytes. Inflammation depolymerizes it, so viscosity falls as inflammation rises.

String test. Normal fluid expressed from a syringe forms a continuous string of 4 to 6 cm before breaking; inflammatory fluid drips like water.

Mucin clot (Ropes) test. Adding fluid to 2 to 5% acetic acid precipitates hyaluronate. A normal specimen forms a tight, firm clot in clear solution; a poor or friable clot in a cloudy solution indicates inflammatory depolymerization.

Practical consequence. High viscosity interferes with automated counting and pipetting. Viscous specimens are pretreated with hyaluronidase (or a drop of it added before the chamber count) so that cells disperse and can be counted accurately.

Additional Cytologic Findings

LE (lupus erythematosus) cells : neutrophils that have engulfed a homogeneous mass of antibody-coated nuclear material; associated with systemic lupus erythematosus.

RA cells (ragocytes) : neutrophils containing dark cytoplasmic granules of immune complexes, seen in rheumatoid arthritis.

Reiter cells : vacuolated macrophages that have phagocytosed neutrophils, associated with reactive arthritis.

Chylous versus pseudochylous effusion : a true chylous effusion follows thoracic duct disruption, is milky white with triglycerides above 110 mg/dL and chylomicrons present; a pseudochylous effusion arises in long-standing chronic inflammation, has a greenish iridescent sheen, cholesterol crystals, and no chylomicrons.